What is the role of Amiodarone (antiarrhythmic medication) in treating atrial flutter?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Amiodarone is a reasonable option for maintaining sinus rhythm in patients with symptomatic, recurrent atrial flutter, particularly in those with heart failure or significant underlying heart disease. According to the 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia 1, amiodarone can be useful in maintaining sinus rhythm in patients with symptomatic, recurrent atrial flutter, with the drug choice depending on underlying heart disease and comorbidities.

Some key points to consider when using amiodarone for atrial flutter include:

  • Amiodarone has significant toxicities, so it is used only when other treatments are contraindicated or ineffective 1
  • Administration is reasonable, particularly in patients with heart failure or significant underlying heart disease 1
  • The dose and administration of amiodarone may vary depending on the individual patient's needs and medical history
  • Regular monitoring of thyroid, liver, and pulmonary function is necessary due to the potential side effects of amiodarone

It's also important to note that catheter ablation is a reasonable alternative to antiarrhythmic drugs like amiodarone for patients with recurrent symptomatic non–CTI-dependent flutter, and may be considered as primary therapy after carefully weighing potential risks and benefits of treatment options 1. Ultimately, the decision to use amiodarone or another treatment option should be made on a case-by-case basis, taking into account the individual patient's medical history, underlying heart disease, and other factors.

From the Research

Amiodarone for Atrial Flutter

  • Amiodarone is an antiarrhythmic medication that has been used to treat various types of arrhythmias, including atrial flutter 2, 3, 4.
  • The medication has been shown to be effective in maintaining stability of sinus rhythm and preventing recurrent arrhythmias 2, 3.
  • Amiodarone can be used for acute ventricular rate control in atrial fibrillation and flutter, although it is not always the first-line treatment 5.
  • The drug has a unique mechanism of action, with class I, II, III, and IV antiarrhythmic effects, making it a useful option for treating complex arrhythmias 3.

Indications and Usage

  • Amiodarone is commonly prescribed for long-term rhythm control in atrial fibrillation patients, although its use is recommended with caution due to its extracardiac toxicity 6.
  • The medication is often used in patients with significant structural heart disease, but its use in patients without structural heart disease is more controversial 6.
  • Amiodarone can be used to treat atrial flutter, but its use should be individualized based on the patient's clinical situation and medical history 2, 3.

Safety and Side Effects

  • Amiodarone has a high toxicity profile, with potential side effects including thyroid abnormalities, pulmonary fibrosis, and transaminitis 3, 6, 4.
  • The medication can interact with several other drugs, including warfarin, simvastatin, and atorvastatin, and many HIV antiretroviral medications 4.
  • Routine monitoring is recommended to minimize the risk of side effects and ensure safe use of the medication 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Amiodarone - a 'broad spectrum' antiarrhythmic drug.

Cardiovascular & hematological disorders drug targets, 2010

Research

Amiodarone: A Comprehensive Guide for Clinicians.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2020

Research

Is amiodarone still a reasonable therapeutic option for rhythm control in atrial fibrillation?

Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.